1
|
Paritala PK, Yarlagadda PKDV, Kansky R, Wang J, Mendieta JB, Gu Y, McGahan T, Lloyd T, Li Z. Stress-Relaxation and Cyclic Behavior of Human Carotid Plaque Tissue. Front Bioeng Biotechnol 2020; 8:60. [PMID: 32117939 PMCID: PMC7026010 DOI: 10.3389/fbioe.2020.00060] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2019] [Accepted: 01/23/2020] [Indexed: 12/12/2022] Open
Abstract
Atherosclerotic plaque rupture is a catastrophic event that contributes to mortality and long-term disability. A better understanding of the plaque mechanical behavior is essential for the identification of vulnerable plaques pre-rupture. Plaque is subjected to a natural dynamic mechanical environment under hemodynamic loading. Therefore, it is important to understand the mechanical response of plaque tissue under cyclic loading conditions. Moreover, experimental data of such mechanical properties are fundamental for more clinically relevant biomechanical modeling and numerical simulations for risk stratification. This study aims to experimentally and numerically characterize the stress-relaxation and cyclic mechanical behavior of carotid plaque tissue. Instron microtester equipped with a custom-developed setup was used for the experiments. Carotid plaque samples excised at endarterectomy were subjected to uniaxial tensile, stress-relaxation, and cyclic loading protocols. Thirty percent of the underlying load level obtained from the uniaxial tensile test results was used to determine the change in mechanical properties of the tissue over time under a controlled testing environment (Control tests). The stress-relaxation test data was used to calibrate the hyperelastic (neo-Hookean, Ogden, Yeoh) and linear viscoelastic (Prony series) material parameters. The normalized relaxation force increased initially and slowly stabilized toward the end of relaxation phase, highlighting the viscoelastic behavior. During the cyclic tests, there was a decrease in the peak force as a function of the cycle number indicating mechanical distension due to repeated loading that varied with different frequencies. The material also accumulated residual deformation, which increased with the cycle number. This trend showed softening behavior of the samples. The results of this preliminary study provide an enhanced understanding of in vivo stress-relaxation and cyclic behavior of the human atherosclerotic plaque tissue.
Collapse
Affiliation(s)
- Phani Kumari Paritala
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Prasad K D V Yarlagadda
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Rhys Kansky
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Jiaqiu Wang
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Jessica Benitez Mendieta
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - YuanTong Gu
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| | - Tim McGahan
- Department of Vascular Surgery, Princess Alexandra Hospital, Brisbane, QLD, Australia
| | - Thomas Lloyd
- Department of Radiology, Princess Alexandra Hospital, Brisbane, QLD, Australia
| | - Zhiyong Li
- School of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane, QLD, Australia
| |
Collapse
|
5
|
Ding H, Xu Y, Wang X, Wang Q, Zhang L, Tu Y, Yan J, Wang W, Hui R, Wang CY, Wang DW. 9p21 is a Shared Susceptibility Locus Strongly for Coronary Artery Disease and Weakly for Ischemic Stroke in Chinese Han Population. ACTA ACUST UNITED AC 2009; 2:338-46. [PMID: 20031605 DOI: 10.1161/circgenetics.108.810226] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Background—
Recent studies on genome-wide association have identified common variants on chromosome 9p21 associated with coronary artery disease (CAD). Given that ischemic stroke and CAD share several aspects of etiology and pathogenesis, we investigated the association of variants on chromosome 9p21 with ischemic stroke and CAD in the Chinese Han population by capturing the majority of diversity in this locus using haplotype-tagging single-nucleotide polymorphisms.
Methods and Results—
We performed a shared control-cases study using 15 tagging single-nucleotide polymorphisms and 2 previously reported susceptibility single-nucleotide polymorphisms spanning 58 kb of the chromosome of 9p21 in a set of 558 patients with ischemic stroke, 510 patients with CAD, and 557 unaffected participants (controls) in the Chinese Han population. The association analyses were performed at both SNP and haplotype levels. We further verified our findings in an independent cohort of 442 ischemic stroke cases and 502 control subjects. In the first study, rs2383206, rs1004638, and rs10757278 in block 3 were significantly associated with CAD but not with ischemic stroke independent of traditional cardiovascular risk factors in additive model (
P
=0.002 to 0.0001, q=0.026 to 0.004). Analysis from all blocks revealed that haplotype profiles of block 3 on 9p21 were significantly different between shared control and cases of CAD (
P
=1.3�10
−10
, q=1.2�10
−9
) and ischemic stroke (
P
=1.7�10
−6
, q=7.7�10
−6
). In the expanded second case-control study, block 3 on 9p21 remained associated with ischemic stroke (
P
=2.6�10
−4
, q=6.3�10
−4
).
Conclusions—
Our results suggest for the first time that 9p21 is a shared susceptibility locus, strongly for CAD and weakly for ischemic stroke, in a Chinese Han population.
Collapse
Affiliation(s)
- Hu Ding
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Yujun Xu
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Xiaojing Wang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Qi Wang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Lan Zhang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Yuanchao Tu
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Jiangtao Yan
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Wei Wang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Rutai Hui
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Cong-Yi Wang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| | - Dao Wen Wang
- From the Institute of Hypertension and Department of Internal Medicine (H.D., Y.X., Q.W., L.Z., J.Y., W.W., D.W.W.), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Center for Craniofacial and Dental Genetics School of Dental Medicine (X.J.W.), University of Pittsburgh, Pa; Xinhua Hospital (Y.T.), Hubei, China; Fuwai Hospital (R.H.), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; Center for Biotechnology and
| |
Collapse
|